Maternal vitamin use, infant C677T mutation in MTHFR, and isolated cleft palate risk [4]

American Journal of Medical Genetics

Volumn 85, Issue 1, 1999, Pages 84-85

  Shaw, G M ^a   Todoroff, K ^a   Finnell, R H ^a   Rozen, R ^a   Lammer, E J ^a  

^a California Birth Defects Monitoring Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; FOLIC ACID; VITAMIN;

CLEFT PALATE; ENZYME ACTIVITY; GENE; GENE MUTATION; HOMOZYGOSITY; HUMAN; LETTER; POLYMERASE CHAIN REACTION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CASE-CONTROL STUDIES; CLEFT PALATE; GENOTYPE; HUMANS; INFANT, NEWBORN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; OXIDOREDUCTASES; RISK FACTORS; VITAMINS;

EID: 0033516526     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990702)85:1<84::AID-AJMG15>3.0.CO;2-V     Document Type: Letter

References (9)